Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

 2,200.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 3,950.00
  • 52 Week Low: 1,835.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 0
  • Market Cap: £114.95m
  • Beta: 0.30

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
17-Oct-16 FinnCap Corporate 1,462.50p - 1,450.00p Reiteration
22-Aug-16 FinnCap Corporate 1,160.00p - 1,250.00p Reiteration
07-Apr-16 FinnCap Corporate 1,032.50p - 1,250.00p Reiteration
17-Nov-15 FinnCap Corporate 1,267.50p - 1,040.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,200.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 3,950.00
52 Week Low 1,835.00
Volume 0
Shares Issued 5.22m
Market Cap £114.95m
Beta 0.30

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 06-Nov-25 10-Apr-25
Paid 21-Nov-25 25-Apr-25
Amount 80.00p 70.00p

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page